| OAC0302 | Drug overdoses are reducing the gains in life expectancy of people living with HIV (PLWH) in British Columbia, Canada | Oral abstract session with live Q&A | C12 |
| OAC0303 | Harm reduction revisited: The causal effect of the Dutch approach towards people who inject drugs on HIV, hepatitis B and C infection risk | Oral abstract session with live Q&A | C45 |
| OAC0304 | Are harm reduction projects for people who inject drugs in Ukraine improving HIV prevention and treatment outcomes? | Oral abstract session with live Q&A | C41 |
| OAC0305 | Assessing implementation and impact of an educational intervention for safer injection among people who inject drugs in Europe: A multi-country mixed-method study | Oral abstract session with live Q&A | C41 |
| OAC0306 | Progress in HIV prevention interventions uptakes among people who inject drugs in Unguja Island, Zanzibar: Analyses of bio-behavioral surveys in 2007, 2012 and 2019 | Oral abstract session with live Q&A | C8 |
| OAC0402 | Feasibility of implementation, acceptability and preliminary effects of a pilot, peer-led HIV self-testing intervention in a hyperendemic fishing community in rural Uganda | Oral abstract session with live Q&A | C34 |
| OAC0403 | HIV self-tests free distribution in Brazil: An effective strategy for reaching undiagnosed key populations | Oral abstract session with live Q&A | C34 |
| OAC0404 | TRUST: Results of an HIV self-testing intervention for Black or African-American transgender women (TGW) and gay, bisexual and other men who have sex with men (MSM) in New York City | Oral abstract session with live Q&A | C34 |
| OAC0405 | Feasibility of index testing among incarcerated people: Early results from four correctional facilities in Zambia | Oral abstract session with live Q&A | C39 |
| OAC0406 | What's a lab got to do with it? Alliances with private laboratories enhance HIV-case finding among at-risk MSM and transgender women in Central America | Oral abstract session with live Q&A | C49 |